Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce.
Zachary I WillisCarlos R OliveiraMark J AbzugBrenda I AnosikeMonica I ArduraLaura L BioJuri BoguniewiczKathleen ChiotosKevin James DownesSteven P GrapentineAdam L HershSarah M HestonDiego R HijanoW Charles HuskinsScott H JamesSarah JonesChristine R LockowitzElizabeth C LloydChristine MacBrayneGabriela M MaronMolly HayesChristine M MillerTheodore H MortonRosemary M OliveroRachel C OrschelnHayden T SchwenkPrachi SinghVijaya L SomaPaul K SueSurabhi B VoraMari M NakamuraJoshua WolfPublished in: Journal of the Pediatric Infectious Diseases Society (2024)
There are identifiable clinical characteristics that enable risk stratification for patients at risk for severe COVID-19. These risk factors can be used to guide the treatment of hospitalized and non-hospitalized children and adolescents with COVID-19 and to guide preventative therapy where options remain available.